Abstract
Total body irradiation (TBI) can cause short stature because of decreased growth hormone (GH) and skeletal abnormalities. To evaluate the plasma concentrations of markers of bone formation (osteocalcin and procollagen type 1 amino-terminal propeptide, P1NP) and resorption (carboxy-terminal telopeptide, CTX), in patients (n=65) who had been given TBI at 6.6±0.4 years were evaluated at 9.8±0.4 years. Patients given single 10 Gy or fractionated 12 Gy TBI had similar characteristics, except that plasma insulin-like growth factor (IGF-1) was lower in those given a single 10 Gy. Seven had lower osteocalcin and two had higher CTX than controls. Bone markers (as zs) were positively correlated (osteocalcin with P1NP, ρ=0.42, P=0.0007; osteocalcin with CTX, ρ=0.3, P<0.02), but not P1NP with CTX. Plasma osteocalcin and CTX were also positively correlated with plasma IGF-1, but not with growth rate during the first year on GH (n=28). Adult height was −2.5±0.2 s.d.s. (n=49). Those irradiated when young (P=0.0002) or given single TBI lost more height between TBI and adult height. Most TBI patients had normal bone formation and resorption markers. Thus, impaired bone turnover is probably not the cause of their short stature and poor response to GH.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fletcher BD, Crom DB, Krance RA, Kun RE . Radiation-induced bone abnormalities after bone marrow transplantation for childhood leukemia. Radiology 1994; 191: 231–235.
Brauner R, Adan L, Souberbielle JC, Espérou H, Michon J, Devergie A et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 1997; 130: 785–792.
Couto-Silva AC, Trivin C, Esperou H, Michon J, Baruchel A, Lemaire P et al. Final height and gonad function after total body irradiation during childhood. Bone Marrow Transplant 2006; 38: 427–432.
Cohen A, Rovelli A, Bakker B, Uderzo C, Van Lint M-T, Espérou H et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the working party for late effects-EBMT. Blood 1999; 93: 4109–4115.
Cohen A, Rovelli A, Van-Lint MT, Uderzo C, Morchio A, Pezzini C et al. Final height of patients who underwent bone marrow transplantation during childhood. Arch Dis Child 1996; 74: 437–440.
Sempe M, Pedron G, Roy Pernot MP . Auxologie, méthode et sequences. Theraplix ed Paris, 1979.
Rolland-Cachera MF, Cole TJ, Sempé M, Tichet J, Rossignol C, Charraud A . Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991; 45: 13–21.
Tanner JM, Goldstein H, Whitehouse RH . Standards for children's height at ages 2–9 years allowing for heights of parents. Arch Dis Child 1970; 45: 755–762.
Bussières L, Souberbielle JC, Pinto G, Adan L, Noel M, Brauner R . The use of insulin-like growth factor I reference values for the diagnosis of growth hormone deficiency in prepubertal children. Clin Endocrinol 2000; 52: 735–739.
Adan L, de Lanversin M-L, Thalassinos C, Souberbielle J-C, Fischer A, Brauner R . Growth after bone marrow transplantation in young children conditioned with chemotherapy alone. Bone Marrow Transplant 1997; 19: 253–256.
Saggese G, Baroncelli GI, Bertelloni S, Barsanti S . The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996; 81: 3077–3083.
Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM . Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 1997; 82: 2423–2428.
Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC . Growth hormone and bone. Endocr Rev 1998; 19: 55–79.
Tobiume H, Kanzaki S, Hida S, Ono T, Moriwake T, Yamauchi S et al. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab 1997; 82: 2056–2061.
Spagnoli A, Branca F, Spadoni GL, Cianfarani S, Pasquino AM, Argiro G et al. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment. J Clin Endocrinol Metab 1996; 81: 3589–3593.
Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G . Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 1993; 122: 37–45.
Gascoin-Lachambre G, Trivin C, Brauner R, Souberbielle J-C . Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: comparison of intrauterine growth retardation and idiopathic short stature. Growth Horm IGF Res 2007; 17: 194–200.
Lee WY, Baek KH, Rhee EJ, Tae HJ, Oh KW, Kang MI et al. Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation. Bone Marrow Transplant 2004; 34: 89–94.
Baek KH, Lee WY, Oh KW, Kim HS, Han JH, Kang MI et al. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism. J Clin Endocrinol Metab 2004; 89: 1246–1254.
Lee WY, Sho SW, Oh ES, Oh KW, Lee JM, Yoon KH et al. The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 2002; 87: 329–335.
Leung TF, Hung ECW, Lam CWK, Li CK, Chu Y, Chik KW et al. Bone mineral density in children with thalassemia major: determining factors and effects of bone marrow transplantation. Bone Marrow Transplant 2005; 36: 331–336.
Nysom K, Holm K, Fleischer Michaelsen K, Hertz H, Jacobsen N, Müller J et al. Bone mass after allogeneic BMT for childhood leukemia or lymphoma. Bone Marrow Transplant 2000; 25: 191–196.
Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, Dawson S et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 1996; 11: 1774–1783.
Acknowledgements
We thank Monique Pouillot and Marie-Christine Perret for technical help and Dr Owen Parkes for editing the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Couto-Silva, AC., Trivin, C., Espérou, H. et al. Bone markers after total body irradiation in childhood. Bone Marrow Transplant 45, 437–441 (2010). https://doi.org/10.1038/bmt.2009.198
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.198
Keywords
This article is cited by
-
Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation
Orphanet Journal of Rare Diseases (2014)